Tofacitinib for the treatment of alopecia areata and variants in adolescents
January 2017
in “Journal of the American Academy of Dermatology”
TLDR Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.
The study from 2017 assessed the use of tofacitinib in treating adolescents with alopecia areata (AA) and its variants. It involved 13 patients aged 12 to 17, who were observed for an average of 6.5 months. The treatment led to clinically significant hair regrowth in 9 patients, with a median improvement in SALT score of 93%. Side effects were mild, including headaches and mild liver enzyme elevations. Despite promising results, the study's retrospective design, the small number of participants, and the absence of a control group were noted as limitations. The authors recommended further prospective trials to confirm the efficacy and safety of tofacitinib for AA in adolescents.
View this study on doi.org →
Cited in this study
research Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.
research Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review
People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.
research Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.
research Efficacy of tofacitinib in treatment of alopecia universalis in two patients
Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.
research Topical Ruxolitinib for the Treatment of Alopecia Universalis
research Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.
research Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.
research Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.
Related
research Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.